New Minimally Invasive Treatment for Uterine Fibroids Demonstrated in Trieste

On June 10, 2026, the IRCCS Materno-Infantile Burlo Garofolo in Trieste, Italy, showcased a groundbreaking minimally invasive procedure for treating uterine fibroids. This technique, known as interstitial myolysis using microwave or radiofrequency thermotherapy, offers a novel approach to managing these common benign tumors without removing the uterus or requiring extensive recovery time.

Understanding Uterine Fibroids

Uterine fibroids are noncancerous growths in the uterine muscle that affect many women during their reproductive years. They can cause heavy menstrual bleeding, pelvic pressure, and, in some cases, urinary or intestinal symptoms, infertility, or pregnancy complications. While often manageable with medication, surgical interventions like hysterectomy are frequently considered for severe cases.

Overview of the New Procedure

The procedure, presented during a public event at the Burlo Garofolo, involves targeting fibroid tissue with heat generated by microwave or radiofrequency energy. Guided by ultrasound, a probe is inserted either through the vagina or a small incision to deliver thermal energy directly to the fibroid. This method destroys the abnormal tissue while preserving the uterus, making it a viable option for women who wish to maintain their fertility.

Key advantages of the technique include:

• Shorter hospital stays and faster recovery compared to traditional surgery
• Reduced risk of postoperative complications
• Minimal scarring
• Potential to avoid hysterectomy

Clinical Presentation and Expert Insights

The procedure was discussed by Professor Antonio La Marca, director of the Department of Obstetrics and Gynecology at the University of Modena Policlinico, during a session led by Professor Giuseppe Ricci, head of the Obstetrics and Gynecology Clinic at the Burlo Garofolo and Dr. Francesca Buonomo, director of Advanced Gynecological Ultrasound Diagnostics at the same institution.

Experts emphasized that the treatment’s applicability must be evaluated on a case-by-case basis, depending on factors such as fibroid size, location, and patient health. The event included a review of clinical cases to illustrate the procedure’s practical implementation.

Implications for Patient Care

This innovation represents a significant advancement in gynecological care, particularly for women seeking conservative alternatives to hysterectomy. By minimizing surgical trauma and recovery time, the technique aligns with broader trends in minimally invasive medicine aimed at improving patient outcomes and quality of life.

As research and clinical adoption of the procedure continue, it may expand access to effective, uterus-preserving treatments for women with uterine fibroids.